CyPath® Lung Connect Forums Titelbild

CyPath® Lung Connect Forums

CyPath® Lung Connect Forums

Von: CyPath® Lung by bioAffinity Technologies
Jetzt kostenlos hören, ohne Abo

Das größte Angebot der Saison | 0,99 € pro Monat für die ersten 3 Monate + 15 € Audible-Guthaben

Danach 6,99 €/Monat. Bedingungen gelten. Monatlich kündbar.
Über diesen Titel
CyPath® Lung Connect brings together leading voices in pulmonology, oncology, and lung health to explore the evolving landscape of early lung cancer detection. Through clinical insights, real-world case studies, and expert conversations, the series covers topics such as lung cancer screening, risk stratification, early diagnosis, clinical decision-making and emerging technologies. From screening through survivorship, the series highlights perspectives shaping the future of lung health, including the role of noninvasive diagnostic technologies like CyPath® Lung.CyPath® Lung by bioAffinity Technologies Hygiene & gesundes Leben
  • From CT to Sputum: Rethinking Lung Nodule Risk in Veterans
    Sep 14 2026

    Veterans face disproportionately high rates of lung cancer, often diagnosed too late for the most effective treatments. In this episode, NAVREF CEO Rashi Romanoff and RWJBarnabas Health pulmonologist Dr. Michael Nicholson explore how CyPath Lung, a non-invasive, home-based sputum test powered by AI, can transform lung cancer screening and early detection for veterans.


    Mehr anzeigen Weniger anzeigen
    19 Min.
  • Real-World Lung Nodule Cases: Risk Stratification, Multidisciplinary Collaboration and the Role of CyPath® Lung
    Aug 12 2026

    In this episode, a multidisciplinary panel of pulmonology, thoracic surgery and oncology experts discusses real-world lung nodule cases and how noninvasive CyPath® Lung testing can help refine risk stratification. The panel explores when testing may support decisions to pursue biopsy, when a negative result may help avoid unnecessary invasive procedures, and how multidisciplinary collaboration can improve the management of patients with indeterminate lung nodules. The experts also look ahead to the evolving role of noninvasive testing in lung nodule management.


    Mehr anzeigen Weniger anzeigen
    38 Min.
  • Navigating Lung Nodules in High-Risk Patients: The Role of CyPath® Lung
    Aug 4 2026

    In this episode, a multidisciplinary panel - an interventional pulmonologist, thoracic surgeon, and medical oncologist - explores the growing challenge of indeterminate lung nodules in high-risk patients. The experts discuss the limitations of current risk-stratification approaches and how CyPath® Lung, a noninvasive sputum-based test, can provide objective information to help clinicians better assess the likelihood of malignancy and guide decisions about follow-up, surveillance, or biopsy.


    Mehr anzeigen Weniger anzeigen
    24 Min.
adbl_web_anon_alc_button_suppression_t1
Noch keine Rezensionen vorhanden